Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 10.51
+0.36 (3.55%)
Nov 2, 2026, 2:25 PM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 4.19 billion as of October 30, 2026. It is the 13,159th most valuable company in the world and the 3,314th biggest in China. Its market cap has increased by 8.80% in one year.
Market Cap
4.19B
Enterprise Value
3.63B
Revenue
1.28B
Global Rank
Country Rank
#3,314 China
PE Ratio
79.96
ChartMarket Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 4.19B, a decrease of -42.76%. That is a compound annual growth rate of -10.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 4.19B | 13.62% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
| Sep 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Strong Biotechnologies,Inc. | 7.35B |
| Amoy Diagnostics | 7.33B |
| Shanghai Runda Medical Technology | 5.91B |
| Maccura Biotechnology Co.Ltd | 5.43B |
| Cowealth Medical China | 4.19B |
| Medicalsystem Biotechnology | 3.97B |
| Guangdong Hybribio Biotech | 3.55B |
| Thalys Medical Technology Group | 3.46B |